Effect of GLP-1 on Postprandial Lipid Metabolism

NCT01760772 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

42

Enrollment

OTHER

Sponsor class

Conditions

Heart Disease

Interventions

DRUG: Exendin-9
DRUG: GLP-1
OTHER: saline

Sponsor

David Dalessio